The Indian government plans to offer incentives to promote local manufacturing of GLP-1 drugs by 2026, which will impact pricing and availability. Brazil In Brazil, the first generics of semaglutide (Ozempic) will launch in March 2026 after Novo Nordisks patent expires
While compounded meds are affordable, brand-name options still run hundreds to thousands per month, and Hims doesnt provide reimbursement pathways
Researchers are encouraged to verify batch details before commencing laboratory investigations
Gamma-glutamyl transpeptidase deficiency leads to glutathionuria, glutathionemia, growth failure, cataracts, lethargy, shortened life span, and infertility
N-acetylcysteine and methionine (Sigma-Aldrich) were dissolved in the APAP media at the indicated concentrations